SEROPREVALENCE OF TRANSFUSION TRANSMITTED INFECTIONS AMONG BLOOD DONORS AT TERTIARY CARE HOSPITAL OF SOUTHERN ODISHA

Main Article Content

Dr. Rashmi Panigrahi
Dr. Rashmita Panigrahi
Dr. Sarada Prasanna Sahoo
Dr. Manu Mangat Marandi
Dr. Sabita Palai

Keywords

transfusion transmitted infections (TTI), hepatitis B virus (HBV), Human Immunodeficiency Virus (HIV)

Abstract

Background


Blood transfusion service is crucial for saving lives but can also pose a life-threatening risk. Sero prevalence of transfusion transmitted infections (TTI) are crucial for determining the safety of blood and blood product and to provide safe and risk free blood to the recipients.


Aims & Objective


The study aimed to estimate TTI risk and trends over five years, evaluating the safeness of blood supply and effectiveness of TTI screening.


Method


A retrospective study was undertaken to determine the seroprevalence of TTI among the blood donors who donated blood at Odisha Blood Centre, Maharaja Krushna Chandra Gajapati Medical College & Hospital, Berhampur, between January 2019 and December 2023. Each blood unit was tested by ELISA method for HIV, Hepatitis B and Hepatitis C virus. Non-reactive units are further subjected to NAT test. Syphilis and Malaria was tested by antigen rapid diagnostic test. All reactive blood units were discarded as per standard operating system of blood centre. This information was extracted from the data base of blood centre.


Results


The study comprised of a total blood donation of 142366 blood donors during the five-years period. The overall seroprevalence rate was 2.17%. The seroprevalence rate of HIV was 0.092%, that of HBV was 1.99%, HCV was 0.066%, Syphilis was 0.22% and Malaria was 0.005% among all the blood donors who showed reactivity for TTI during the five-year period.


 


Conclusion


There is a need to increase public awareness regarding voluntary donation and its benefits. Adaptation of other newer techniques to detect TTIs as Nucleic acid amplification test (NAT) and Chemiluminescence assay (CLIA) for all viral borne diseases like HBV, HCV, and HIV, CLIA and multiplex flow immunoassay for detecting Syphilis and Enzyme immunoassays (EIA) to detect Malaria along with conventional testing methods. Thorough meticulous screening of blood donors, the implementation of advanced methods for identifying TTIs, stringent post donation counselling and notification with further follow up are strongly advised to guarantee the safety of blood for recipients.

Abstract 58 | PDF Downloads 8

References

[1] Kumari S, Prasad A, Saroj U, Kumar P, Verma S, Kiran KA, Kumar D. Seroprevalence of Hepatitis C Virus Among Blood Donors in a Tribal-Preponderant Region of India. Cureus 2024;16(6):e62934.
[2] Divya S, Vanishree R, Sharat J. Sero-positivity of transfusion transmitted infections and reactive donors response to counselling among healthy blood donors. Indian Journal of Pathology and Oncology 2021;8:120-7.
[3] Tiwari AK, Upadhyay AP, Arora D, Wadhwa T, Aggarwal G, Pabbi S, et al. Head-to-head comparison of Enzyme Linked Immunosorbent Assay (ELISA) and Enhanced Chemiluminescence Immunoassay (ECLIA) for the detection of Transfusion Transmitted Disease (TTD) Markers; HIV, HCV and HBV in blood donors, in India. J Virol Methods 2020;285:113962.
[4] Faddy HM, Osiowy C, Custer B, Busch M, Stramer SL, Adesina O, et al. International review of blood donation nucleic acid amplification testing. Vox Sang 2024;119:315-25.
[5] WHO. Screening donated blood for transfusion transmissible infections, Who.int. 2019. [Cited 22 December 2019]. https://www.who.int/ blood safety / Screening Donated Blood for Transfusion.pdf
[6] Chattoraj A, Bhel R, Kataria V. Infectious disease markersin blood donors. Med J Armed Forces India 2008;64(1):33-5.
[7] Pallavi P, Ganesh CK, Jayashree K, Manjunath GV. Seroprevalence and trends in transfusion transmitted infections among blood donors in a university hospital blood bank: a 5 year study. Indian J Hematol Blood Transfus 2011;27(1):1-6.
[8] Varma AV, Malpani G, Kosta S, Malukani K, Sarda B, Raghuvanshi A. Seroprevalence of transfusion transmissible infections among blood donors at a tertiary care teaching hospital in central India. International Journal of Contemporary Medical Research [IJCMR][Internet]. 2019;6(12):10-21276.
[9] Garg S, Mathur DR, Garg DK. Comparison of seropositivity of HIV, HBV, HCV and syphilis in replacement and voluntary blood donors in western India. Indian J Pathol Microbiol 2001;44 (4):409-12.
[10] Bassi R, Singal P, Kaur L, Kapoor U, Bansal S. The evaluation of pattern of whole blood donor deferrals in a tertiary care center of North India. Asian Journal of Pharmaceutical and Clinical Research, vol. 17, no. 5, May 2024;17(5):171-4.
[11] Karmakar PR, Shrivastava P, Ray TG. Seroprevalence of transfusion transmissible infections among blood donors at the blood bank of a Medical College of Kolkata. Indian J Public Health 2014 ;58(1):61-4.
[12] Mandal R, Mondal K. Transfusion transmissible infections among blood donors from a sub-Himalayan rural tertiary care centre in Darjeeling, India. J Tradit Complement Med. 2015;6(3):224-9.
[13] Ahmed N, Kumar R. A guide to organizing a voluntaryblood donation camp. International Journal of Blood Transfusion and Immunohematology (IJBTI). 2013;3:12-7.
[14] Towards 100% Voluntary Blood Donation: A Global Framework for Action. Geneva: World Health Organization; 2010. 2, Voluntary blood donation: foundation of a safe and sufficient blood supply. Available from: https://www.ncbi.nlm.nih.gov/books/NBK305666.
[15] Mukherjee S, Agarwal SK, Tiwari S. Seroprevalence of transfusion transmitted infections among blood donors attending a tertiary care hospital of Western Odisha. J Evolution Med Dent Sci 2020;9:483-7.
[16] Shrivastava M, Mishra S, Navaid S. Time trend and prevalence analysis of transfusion transmitted infections among blood donors: a retrospective study from 2001 to 2016. Indian J Community Med 2023;48(2):274-280.
[17] Patel NH, Sapre JP, Vyas KN, Radadia HN. Seroprevalence of Transfusion Transmitted Infections among Blood Donors at the Tertiary Care Hospital in Nadiad, Gujarat, India. J Clin of Diagn Res 2024;18(2): EC34-7.
[18] Gita N, Dushyant G. Trends of transfusion transmissible diseases among blood donors at Uttarakhand, India. Indian Journal of Community Medicine: Official Publication of Indian Association of Preventive & Social Medicine 2014;39:183-6.
[19] Srikrishna A, Sitalakshmi S, Damodar P. How safe are oursafe donors? Indian J Pathol Microbiol 1999;42 (4):411-6.
[20] Chandra T, Kumar A, Gupta A. Prevalence of transfusiontransmitted infection in blood donors: an Indian experience. Trop Doct 2009;39(3):152-4.
[21] Buseri FI, Muhibi MA, Jeremiale ZA. Seroepidemiology oftransfusion transmissible infectious diseases amongblood donors in Osoglor, southwest Nigeria. Blood Transfus2009;7:293-9.
[22] Terenpuntsag B, Oupbileg L, Nelson K, et al. Prevalence of infectious diseases among Mangolian blood donors. JInfect Dev Ctries 2008;2 (1):73-5.
[23] Adhikary M, Mazumdar M, Mukhopadhyay SG, Phukan JP, Sana PK, Jain BB. Seroprevalence of transfusion-transmitted infections among blood donors in a newly established medical college of Eastern India. Iraqi Journal of Hematology 2021;10(2):134-8.
[24] Inamdar DP, Anuradha B. Seroprevalence of transfusion transmissible infections among blood donors at tertiary care hospital in southern Telangana-A 3 year cross sectional study. Indian J Microbiol Res 2018;5(4):446-50.
[25] Mahapatra S, Ray GK, Panigrahi R, Parida P. The incidence and spectrum of transfusion transmitted infections among the blood donors. Int J Res Med Sci 2018;6(3):904-7.
[26] Pharmacopoeia I. Ministry of health and family welfare. Government of India 1996;2(1996):350.
[27] "Sankalak: Status of National AIDS & STD Response 2023" report, you would use the following format: National AIDS Control Organisation (2023). Sankalak: Status of National AIDS & STD Response (Fifth edition, 2023). New Delhi: NACO, Ministry of Health and Family Welfare, Government of India.
[28] Deshmukh S, Rathod Y, Thakore S, Jadhav S. Prevalence of transfusion-transmissible infections among voluntary blood donors in a tertiary care hospital. Cureus 2024;16(9):e70469.
[29] Cheema S, Rana V, Kulhari K, Yadav A, Sachdeva A. Prevalence of transfusion transmissible infections and associated factors among healthy blood donors in north Indian population–4-Year experience of licensed blood bank at tertiary care hospital. Journal of Marine Medical Society 2022;24(Suppl 1):S47-52.
[30] Giri PA, Deshpande JD, Phalke DB, Karle LB. Seroprevalence of transfusion transmissible infections among voluntary blood donors at a tertiary care teaching hospital in rural area of India. J Family Med Prim Care 2012;1(1):48-51.
[31] Kaur G, Basu S, Kaur R, Kaur P, Garg S. Patterns of infections among blood donors in a tertiary care centre: a retrospective study. Natl Med J India 2010;23(3):147-9.
[32] Monthly Malaria Information System, National Vector Borne Disease Control Programme. Ministry of Health and Family Welfare, Government of India; (2023). Available at: https://ncvbdc.mohfw.gov.in/index1.php?lang=1&level=1&sublinkid=5879&lid=3957.
[33] Chandekar SA, Amonkar GP, Desai HM, Valvi N, Puranik GV. Seroprevalence of transfusion transmitted infections in healthy blood donors: a 5-year Tertiary Care Hospital experience. Journal of Laboratory Physicians 2017;9(04):283-7.

Most read articles by the same author(s)